Back to Trials
NCT06158607NARecruiting

Pre-exposure Prophylaxis (PrEP) Adherence Intervention for Women with Substance Use Disorders

The University of Texas Health Science Center, Houston

Start Date

6/7/2022

Completion Date

5/30/2025

Summary

The goal of this clinical trial is to test an addiction-clinic based behavioral intervention for increasing PrEP uptake and adherence among women who engage in high-risk sexual behaviors and problematic substance use. The main question it aims to answer is: • If the integrated intervention increase PrEP uptake and adherence compared to standard treatment Participants will * receive provision of PrEP information through 4 counseling sessions * prevention navigation * receive nurse practitioner prescribed PrEP in an addiction treatment setting Researchers will compare intervention group with standard treatment to see if the integrated intervention help increase PrEP uptake and adherence

Eligibility Criteria

Age Range: 18 years to 60 years

Inclusion Criteria: * Black/African American and Hispanic/Latina cisgender women * diagnosed with a Substance use disorder (SUD) per Diagnostic and Statistical Manual of Mental Illnesses (DSM)-5 criteria * HIV negative * sexually active with an opposite sex partner within the past 6 months * not using PrEP for HIV prevention at the time of screening * able to speak, read, and write in English; and * own or have regular access to a smart phone. Exclusion Criteria: * be concurrently participating in another SUD behavioral treatment program * unable to provide informed consent for participation (e.g., have severe cognitive impairment that would interfere with their ability to consent, understand study procedures and/or effectively participate in therapy * have psychological distress that would prohibit them from participating in the study * be unable or unwilling to meet study requirements * be ineligible for PrEP based on Centers for Disease Control and Prevention (CDC)-defined criteria for PrEP based on substance use and sexual risk * have medical contraindications for PrEP (e.g., known renal impairment which can be exacerbated by PrEP use).

Interventions

BEHAVIORAL

Addiction Clinic-Based PrEP Adherence Intervention for Women with Substance Use Disorders

OTHER

Standard of care treatment

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Substance Use

Locations

Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston

Houston, Texas 77054

United States